Editorial Comment
- PMID: 35892273
- DOI: 10.1097/JU.0000000000002740.01
Editorial Comment
Comment in
-
Reply by Authors.J Urol. 2022 Sep;208(3):599-600. doi: 10.1097/JU.0000000000002740.04. Epub 2022 Jul 27. J Urol. 2022. PMID: 35892272 No abstract available.
Comment on
-
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer.J Urol. 2022 Sep;208(3):589-599. doi: 10.1097/JU.0000000000002740. Epub 2022 Jul 27. J Urol. 2022. PMID: 35892270
Publication types
LinkOut - more resources
Full Text Sources